HOME >> BIOLOGY >> NEWS
Ingredient in Prozac increases risk of extinction for freshwater mussels

SAN FRANCISCO, Sept. 11 - You'd think in a river filled with anti-depressants, freshwater mussels would be, well, happy as clams. Far from it. In fact, a new laboratory study suggests that exposure to Prozac can disrupt the reproductive cycle of these mollusks, potentially increasing their risk of extinction.

The study, one of the first to examine the ecotoxicological effects of Prozac (fluoxetine) on native freshwater mussels, found that the drug caused females to prematurely release their larvae, essentially dooming them. The findings were presented today at the 232nd national meeting of the American Chemical Society, the world's largest scientific society.

"The results from this study were quite alarming," said co-investigator Rebecca Heltsley, a National Research Council Post-Doctoral Fellow at the National Institute of Standards and Technology, Hollings Marine Laboratory in Charleston, S.C. "When larvae are released too early, they are not viable, which only contributes to the problems faced by struggling populations of native freshwater mussels."

About 70 percent of the nearly 300 species of freshwater mussels native to North America are extinct, endangered or declining, according to Heltsley. In the past 100 years, no other widespread North American animal group has experienced such notable collapse, she added.

In some cases, native mussels have been crowded out by invasive species such as the zebra mussel, Heltsley said. In others, native mussels have been devastated by increased sediment loads in rivers, habitat alteration and loss, or killed off by pollutants.

"The presence of Prozac and similar drugs in U.S. rivers and streams has likely compounded the problem," Heltsley said. "It's a big concern because freshwater mussels are such an imperiled group."

Prozac, one of the nation's most prescribed anti-depressant medications, helps relieve depression by increasing the brain's supply of a neuro
'"/>


11-Sep-2006


Page: 1 2 3

Related biology news :

1. Ingredient in Big Macs and sodas can stabilize
2. Ingredient in garlic protects against severe chronic pulmonary hypertension in rats
3. Prozac exposure found to disrupt mussel reproduction
4. Prozacs target revealed
5. Prozac improves learning and memory in fatal brain disease
6. Chickadee, nutchatch presence in conifers increases tree growth, says CU-Boulder study
7. Gene variant increases risk of blindness
8. Study finds Western-style meat-sweet diet increases risk of breast cancer in postmenopausal women
9. Endometriosis increases the risk of certain cancers
10. Gene variant increases risk for alcoholism following childhood abuse
11. New treatment increases life time expectancy of patients suffering from advanced liver cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/14/2019)... ... , ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem ... trial for stem cell treatment of knee osteoarthritis . The first treatment came shortly ... VetStem Biopharma. , In July of 2019, PSC received FDA approval for ...
(Date:11/12/2019)... ... November 12, 2019 , ... ... in the design and manufacturer of technical ergonomic seating solutions, announced this ... compliant with Healthier Hospital Initiative guidelines. Established by Practice Greenhealth, a health ...
(Date:11/12/2019)... ... November 12, 2019 , ... The Arnold and Mabel Beckman ... research institutions for its Instrumentation Grant for Advanced Light-Sheet Microscopy and Data ... site for the acquisition of instrumentation, development and maintenance; support for data science ...
Breaking Biology News(10 mins):
(Date:10/30/2019)... ... October 30, 2019 , ... Western University of ... innovation and technology play in educating the next generation of health care providers. ... and presentations by WesternU administrators and representatives of companies working with the University ...
(Date:10/26/2019)... ... October 24, 2019 , ... Sparks Marketing Group, ... (BMMG), a boutique healthcare-specific marketing firm, to strengthen the agency’s growing focus ... Division. , Healthcare clients in pharma, bio-therapeutics, medical device and healthcare technologies currently ...
(Date:10/22/2019)... ... , ... DermBiont, a clinical stage microbiome biotechnology company developing ... safety endpoints, with no application site reactions and no adverse events, in a ... tinea pedis (athlete’s foot). Additionally, the trial demonstrated a clinical response with improvement ...
(Date:10/10/2019)... ... October 09, 2019 , ... The ... Principal Deputy Commissioner, FDA, as a newly-confirmed keynote speaker for the 2019 ... Vegas, Nevada USA. , Dr. Abernethy, a hematologist/oncologist and palliative medicine physician, is ...
Breaking Biology Technology:
Cached News: